Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 26;10(7):e28118.
doi: 10.1016/j.heliyon.2024.e28118. eCollection 2024 Apr 15.

Anti- Staphylococcus aureus potential of compounds from Ganoderma sp.: A comprehensive molecular docking and simulation approaches

Affiliations

Anti- Staphylococcus aureus potential of compounds from Ganoderma sp.: A comprehensive molecular docking and simulation approaches

Trang Thi Thu Nguyen et al. Heliyon. .

Abstract

In this study, a series of secondary metabolites from Ganoderma sp. were screened against Staphylococcus aureus protein targets, including as phosphotransacetylase, clumping factor A, and dihydrofolate reductase, using molecular docking simulations. The chemicals that showed the strongest binding energy with the targeted proteins were ganodermanontriol, lucidumol B, ganoderic acid J, ergosterol, ergosterol peroxide, 7-oxoganoderic acid Z, ganoderic acid AM1, ganosinoside A, ganoderic acid D, and 24R-ergosta-7,2E-diene-3β,5α,6β-triol. Interestingly, ganosinoside A showed the greatest affinity for the protein clumping factor A, a result validated by molecular dynamic simulation. Additionally, three natural Ganoderma sp. Strains as Ganoderma lingzhi VNKKK1903, Ganoderma lingzhi VNKK1905A2, and Amauroderma subresinosum VNKKK1904 were collected from Kon Ka Kinh National Park in central land of Vietnam and evaluated for their antibacterial activity against Staphylococcus aureus using an agar well diffusion technique. These results suggest that the fungal extracts and secondary metabolites may serve as valuable sources of antibiotics against Staphylococcus aureus. These findings provided an important scientific groundwork for further exploration of the antibacterial mechanisms of compounds derived from Ganoderma sp. in future research.

Keywords: Ganoderma; Molecular docking simulation; Molecular dynamic; Staphylococcus aureus.

PubMed Disclaimer

Conflict of interest statement

The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Trang Thi Thu Nguyen reports financial support was provided by PhD Scholarship Programme of the Vingroup Innovation Foundation (VINIF), Vingroup Big Data Institute (VINBIGDATA), code VINIF.2020.TS.68 (TTTN). Trang Thi Thu Nguyen reports financial support was provided by Vietnam National University, Ho Chi Minh City (VNU-HCM) under grant number C2021-18-12.

Figures

Fig. 1
Fig. 1
The 3D structure of (A) dihydrofolate reductase, (B) clumping factor A and (C) Phosphotransacetylase.
Fig. 2
Fig. 2
Ergosterol peroxide and dihydrofolate reductase interaction.
Fig. 3
Fig. 3
Ganosinoside A and clumping factor A interaction.
Fig. 4
Fig. 4
Ganolucidic acid B and phosphotransacetylase interaction.
Fig. 5
Fig. 5
Dynamic simulation between ganosinoside A and clumping factor A for 100 ns. (A) RMSD. (B) RMSF. (C) Number of hydrogen bond.

References

    1. Olaniyi R., Pozzi C., Grimaldi L., Bagnoli F. Staphylococcus aureus-associated skin and soft tissue infections: anatomical localization, epidemiology, therapy and potential prophylaxis. Curr. Top. Microbiol. Immunol. 2016;409:199–227. doi: 10.1007/82_2016_32. - DOI - PubMed
    1. Pimentel de Araujo F., Monaco M., Del Grosso M., Pirolo M., Visca P., Pantosti A. Staphylococcus aureus clones causing osteomyelitis: a literature review (2000-2020) J. Glob. Antimicrob. Resist. 2021;26:29–36. doi: 10.1016/j.jgar.2021.03.030. - DOI - PubMed
    1. Tong S.Y., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015;28:603–661. doi: 10.1128/cmr.00134-14. - DOI - PMC - PubMed
    1. Gaviria-Agudelo C., Aroh C., Tareen N., Wakeland E.K., Kim M.S., Copley L.A. Genomic heterogeneity of methicillin resistant Staphylococcus aureus associated with variation in severity of illness among children with acute hematogenous osteomyelitis. PLoS One. 2015;10 doi: 10.1371/journal.pone.0130415. - DOI - PMC - PubMed
    1. Malishev R., Salinas N., Gibson J., Eden A.B., Mieres-Perez J., Ruiz-Blanco Y.B., Malka O., Kolusheva S., Klärner F.G., Schrader T., Sanchez-Garcia E., Wang C., Landau M., Bitan G., Jelinek R. Inhibition of Staphylococcus aureus biofilm-forming functional amyloid by molecular tweezers. Cell Chem. Biol. 2021;28:1310–1320. doi: 10.1016/j.chembiol.2021.03.013. - DOI - PMC - PubMed

LinkOut - more resources